Insulin glargine [100 U/mL solution for injection] for the treatment of Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM)
Pre-Cycle 1 | DrugsHTA Council Recommendation (as of 03 October 2022)
As final recommendation, the HTA Council recommends the government financing and inclusion of insulin glargine [100 U/mL solution for injection] for the treatment of Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM) in the Philippine National Formulary (PNF).
Relevant Information
- Status: With Final HTA Council Recommendation and SOH Decision
- Topic Assignment: Internal Assessment
- Policy Question: Should insulin glargine [100 U/mL solution for injection]for the treatment of Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM) be funded by the government and be included in the Philippine National Formulary?
- Secretary of Health Decision: Approved as of 11 October 2022
Evidence and Relevant Documents